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ttp://dx.doi.org/10.1016/j.ajpath.2012.10.022It was previously demonstrated that transforming growth factor b (TGF-b) induces endothelial-to-
mesenchymal transition (EndoMT) in murine lung endothelial cells (ECs) in vitro. Owing to the important
role of caveolin-1 (CAV1) in TGF-b receptor internalization and TGF-b signaling, the participation of
CAV1 in the induction of EndoMT in murine lung ECs was investigated. Pulmonary ECs were isolated from
wild-type and Cav1 knockout mice using immunomagnetic methods with sequential anti-CD31 and anti-
CD102 antibody selection followed by in vitro culture and treatment with TGF-b1. EndoMT was assessed
by semiquantitative RT-PCR for Acta2, Col1a1, Snai1, and Snai2; by immunoﬂuorescence for a-smooth
muscle actin; and by Western blot analysis for a-smooth muscle actin, SNAIL1, SNAIL2, and the a2
chain of type I collagen. The same studies were performed in Cav1/ pulmonary ECs after restoration of
functional CAV1 domains using a cell-permeable CAV1 scaffolding domain peptide. Pulmonary ECs from
Cav1 knockout mice displayed high levels of spontaneous Acta2, Col1A, Snai1, and Snai2 expression,
which increased after TGF-b treatment. Spontaneous and TGF-b1estimulated EndoMT were abrogated by
the restoration of functional CAV1 domains using a cell-permeable peptide. The ﬁndings suggest that
CAV1 regulation of EndoMT may play a role in the development of ﬁbroproliferative vasculopathies.
(Am J Pathol 2013, 182: 325e331; http://dx.doi.org/10.1016/j.ajpath.2012.10.022)Supported by NIH grant RO1 AR055660 (S.A.J.).
A guest editor acted as editor-in-chief for this manuscript. No person at
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The University of Manchester, Manchester, UK.Myoﬁbroblasts are specialized mesenchymal cells that share
features of ﬁbroblasts and smooth muscle cells, display
prominent cytoplasmic stress ﬁbers, and express high levels of
a-smoothmuscle actin (a-SMA)RNAandprotein. These cells
also possess contractile properties and are capable of motion
and tissuemigration (reviewed byHinz et al 1).Myoﬁbroblasts
are considered the main cellular elements responsible for
normal and pathologic ﬁbroproliferative responses owing to
their ability to produce very high levels of interstitial collagens
and other extracellular matrix components characteristic of
ﬁbrotic tissues (reviewed in several studies2e4). Myoﬁbro-
blasts also represent the most abundant mesenchymal cells
present in the stroma of malignant tumors, known as cancer-
associated ﬁbroblasts, which are essential for tumor growth
and progression by providing a permissive and favorable
microenvironment for tumorigenesis.5e7
Numerous studies have shown that myoﬁbroblasts
involved in tissue ﬁbrosis can derive from epithelial cells instigative Pathology.
.a process known as epithelial-to-mesenchymal transition
(reviewed by Kalluri and Neilson8). Recently, a similar
process occurring in endothelial cells (ECs), termed
endothelial-to-mesenchymal transition (EndoMT), has been
described. EndoMT is a process whereby ECs lose their
endothelial-speciﬁc markers and acquire a mesenchymal
cell myoﬁbroblastic phenotype.9,10 Recent studies have
demonstrated that this phenomenon may be an important
source of myoﬁbroblasts in cardiac, pulmonary, and kidney
ﬁbrosis (reviewed by Piera-Velazquez et al11,12).
Caveolin 1 (CAV1) is the most important member of
a family of membrane proteins that are the major coating
Li et alproteins of caveolae (reviewed in other articles13,14). CAV1
plays an important role in the endosomal degradation of
transforming growth factor b (TGF-b) receptors, thus
diminishing or abrogating TGF-bemediated signaling.15,16
Owing to the crucial role of TGF-b and TGF-b pathways in
the initiation, development, and persistence of ﬁbrotic reac-
tions, it has been suggested that CAV1 may participate in the
pathogenesis of ﬁbrotic disorders, such as systemic sclerosis
(SSc) and idiopathic pulmonary ﬁbrosis.17e19 Indeed, our
previous studies have shown that mice lacking Cav1
expression [Cav1 knockout (Cav1 KO) mice] display
a remarkable increase in the amount of interstitial collagen in
the lung, as shown by histopathologic analysis of lung tissues,
and a profound increase (>2.5-fold) in the amount of collagen
per lung, as assessed by hydroxyproline assays.17 In accor-
dance with these observations, we also found that Cav1 was
down-regulated in affected SSc lungs and skin comparedwith
normal Cav1 expression in histopathologically nonaffected
areas.17 Moreover, selective restoration of functional CAV1
domains using a cell-permeable CAV1 scaffolding domain
peptide20 reverted the proﬁbrotic phenotype of dermal and
lung ﬁbroblasts cultured from patients with SSc.17,21
In a previous study, we demonstrated that TGF-b caused
a potent induction of EndoMT in murine pulmonary ECs
in vitro, a process that seemed to be mediated by a remarkable
increase in the levels of the transcriptional repressor
SNAIL1.22Recently, it has been reported that TGF-b signaling
through SMAD-dependent and SMAD-independent pathways
in murine pulmonary ECs and in cultured human dermal
microvascular cells22,23 initiate complex intracellular
signaling cascades, which results in the phenotypic conver-
sion of ECs into mesenchymal cells. A crucial molecule
involved in this process is SNAIL1, a transcriptional repressor
that was previously shown to be involved in the regulation of
epithelial-to-mesenchymal transition by causing potent inhi-
bition of E-cadherin expression.24,25 Owing to the previously
demonstrated important regulatory role of CAV1 on TGF-b
signaling, we investigated the participation of CAV1 in
pulmonary EC transition into myoﬁbroblasts using ECs iso-
lated from Cav1 KO mice.26,27 The studies described herein
demonstrate that pulmonary ECs isolated from Cav1-
deﬁcient mice display spontaneous EndoMT which is further
increased by TGF-b stimulation. These observations suggest
that the decreased levels of CAV1 demonstrated in certain
human ﬁbrotic disorders, including SSc and pulmonary
ﬁbrosis,17,21 may contribute to the pathogenesis of tissue
ﬁbrosis in these disorders through a marked increase in
spontaneous and TGF-bestimulated EndoMT.
Materials and Methods
Materials
Complete endothelial cell medium (ECM) consisting of
basal EC medium supplemented with 5% fetal bovine
serum, 10% EC growth supplement, 100 U/mL of penicillin,326and 100 mg/mL of streptomycin was purchased from Sci-
enCell Research Laboratories (Carlsbad, CA). Anti-CD31
and anti-CD102 were from BD Biosciences (Bedford, MA).
The antibodies for Western blot analysis and indirect
immunoﬂuorescence were a-actin (a-SMA; clone SPM332;
Santa Cruz Biotechnology, Santa Cruz, CA), antietype I
collagen (Rockland Immunochemicals, Gilbertsville, PA),
SNAIL-1 (Santa Cruz Biotechnology), and Cy3-conjugated
secondary antibodies (Sigma-Aldrich, St. Louis, MO). TGF-b
was from R&D Systems (Minneapolis, MN), and EC growth
supplement was from Sigma-Aldrich.
Isolation of Pulmonary ECs
Pulmonary ECs were isolated fromwild-type (WT) andCav1
KO mice by a modiﬁcation of the Marelli-Berg procedure,28
as described previously.22 The generation and establishment
of Cav1 KO mice were as described previously.26,27 Lungs
fromWT and Cav1KOmice were minced and enzymatically
digested with collagenase (30 mg/100 mL in 0.1% bovine
serum albumin) in complete ED medium at 37C for 1 hour
with gentle mechanical agitation. The resulting cell mixture
was ﬁltered through a sterile 75-mm cell strainer. The single
cell suspension obtained was then incubated with rat anti-
mouse CD31 antibody (1:50) at 4C for 45 minutes with
gentle shaking, followed by magnetic bead separation using
goat anti-rat IgG-conjugated microbeads (1:5; Miltenyi
Biotec, Auburn, CA). The isolated ECs were cultured in
complete ECmedium in 2% gelatineprecoated 60-mm tissue
culture dishes until 80% conﬂuent. The cells were trypsinized
and resuspended, and a second immunologic separation was
performed using rat anti-mouse CD102 antibody. The
resulting cells were plated, and the endothelial phenotype and
purity of the preparation were conﬁrmed by evaluating
cellular uptake of DiI-labeled acetylated low-density lipo-
protein (Biomedical Technologies Inc., Stoughton, MA) and
assessing cell morphology as described previously.22 The
purity of the EC preparation was quantitatively assessed by
simultaneously staining with DiI-labeled acetylated low-
density lipoprotein and the nuclear stain DAPI. Ninety-ﬁve
percent to 98% of the cells (determined from DAPI nuclear
staining) were ECs, as determined by their uptake of DiI-
labeled acetylated low-density lipoprotein. All the animal
studies were approved by the Institutional Animal Care and
Use Committee of Thomas Jefferson University.
Culture and Treatment of Pulmonary ECs with TGF-b
Pulmonary ECs from WT and Cav1 KO mice were washed
with serum-free medium and then incubated with 10 ng/mL
of TGF-b1 in EC medium containing 0.5% fetal bovine
serum. The medium was changed and TGF-b1 was replen-
ished every 2 days. The cultured cells were visualized using
an inverted microscope with a Nikon camera (Nikon Instru-
ments, Melville, NY) and SPOT Advanced software version
4.0.9 (SPOT Imaging Solutions, a division of Diagnosticajp.amjpathol.org - The American Journal of Pathology
Figure 1 Spontaneous and TGF-b1estimulated EndoMT in Cav1/
primary pulmonary ECs. A: Pulmonary ECs from two WT mice and two Cav1 KO
mice were treatedwith TGF-b1 for 72 hours andwere immunostained fora-SMA
(red ﬂuorescence). B: Pulmonary ECs from two WT and two Cav1 KO mice were
cultured inmedia alone (Control) or with 10 ng/mL of TGF-b1 for 72 hours, and
protein from cell lysates was electrophoresed and probed in Western blot
analysis for a-SMA. GAPDH was used as loading control. C: Aliquots of culture
media from the same samples shown in B underwent Western blot analysis for
type I collagen. The bars showquantitative densitometry analysis ofa-SMAand
type I collagen using ImageJ software. The values shown are the mean SE of
two separate experiments, each performed in triplicate. Signiﬁcance was
determined by the two-tailed t-test. ***P < 0.001.
Caveolin-1 Deﬁciency Induces EndoMTInstruments, Sterling Heights, MI). On day 3, the cells were
either ﬁxed for immunoﬂuorescence staining or harvested for
Western blot analysis or RT-PCR.
Selective Restoration of Functional CAV1 Domains
in Vitro
Conﬂuent cells between passages 4 and 9 were treated for
24 hours with either the penetratin peptide, a 16-amino acid
cell-permeable peptide corresponding to the homeodomain
of the Drosophila transcription factor Antennapedia
(RQPKIWFPNRRKPWKK), or a peptide consisting of
fusion of the Antennapedia peptide and the peptide corre-
sponding to the scaffolding domain of CAV1 (DGIW-
KASFTTFTVTKYWFY), referred to as cav-1P.20,29 The
peptides were custom synthesized and were used at 2.5- and
5-mM ﬁnal concentrations. Pulmonary ECs were incubated
with or without 10 ng/mL of TGF-b for 24 hours in tripli-
cate for each experiment.
Immunoﬂuorescence Staining
Pulmonary ECs were seeded onto glass culture slides and
treated as described previously herein. After treatment, the cells
were ﬁxed with 3.7% formaldehyde and permeabilized with
0.1% Triton X-100 (Roche Diagnostics GmbH, Mannheim,
Germany) in PBS for 3 minutes. Slides were washed with PBS
and blocked with PBS containing 1% bovine serum albumin at
room temperature for 1 hour, and then theywere incubatedwith
primary antibodies against a-SMA (1:200). Slides were then
incubated with Cy3-conjugated secondary antibodies (1:500)
followed by DAPI (Jackson ImmunoResearch Laboratories
Inc., West Grove, PA) for nuclear staining.
Western Blot Analysis
Treated ECs from 6-well, gelatin-coated plastic tissue culture
plateswerewashedwith cold PBS, harvested using a cell lifter,
centrifuged, and lysed with radioimmunoprecipitation assay
lysis buffer (25 mmol/L Tris-HCl, pH 7.6, 150 mmol/L NaCl,
1% NP-40, 1% Na deoxycholate, and 0.1% SDS) supple-
mented with a complete protease inhibitor cocktail (Roche
Diagnostics, Indianapolis, IN), homogenized using a pellet
pestle motor (Kimble Chase, Vineland, NJ), and subsequently
centrifuged at 13,000  g for 15 minutes at 4C. Cellular
proteins were resolved by SDS-PAGE and were transferred to
nitrocellulose membranes (Invitrogen, Carlsbad, CA). Blots
were blocked for 1 hour in Tris-buffered salineeTween (10
mmol/L Tris-HCl, pH 8.0, 150 mmol/L NaCl, 0.1% Tween
20) containing 5% nonfat dry milk (Bio-Rad Laboratories,
Hercules, CA). For assessment of type I collagen, equal
aliquots of media from each of the cultures were precipitated
with ethanol; the pellets were resuspended in 0.4 mol/L NaCl,
0.5 mol/L Tris-HCl (pH 7.4) buffer and then were digested
with a mixture of trypsin (1 mg/mL) and chymotrypsin
(2.5 mg/mL) at room temperature for 5 minutes, followed byThe American Journal of Pathology - ajp.amjpathol.org5 minutes of treatment with a 1:10 volume of trypsin inhibitor
(5 mg/mL in PBS), and then prepared for SDS-PAGE and
transfer as described previously herein. The membranes
were incubated overnight at 4C with the primary anti-
bodies in a 5% nonfat dry milk/Tris-buffered salineeTween
solution. Membranes were then washed with Tris-buffered
salineeTween and incubated for 1 hour with horseradish
peroxidaseeconjugated secondary antibodies diluted 3000-
fold in 5% nonfat dry milk/Tris-buffered salineeTween.
Signal was detected using an enhanced chemiluminescence
detection kit (Pierce, Rockford, IL) and was collected using
autoradiographyﬁlm (Denville Scientiﬁc,Metuchen,NJ). The
signals were quantiﬁed using ImageJ software version 1.46
(NIH, Bethesda, MD).
Standard and Quantitative RT-PCR
WT and Cav1 KO mouse pulmonary ECs were treated in
duplicate wells of 12-well, gelatin-treated plastic tissue327
Figure 2 Effects of a cell-permeable CAV1 scaffolding domain
peptide (cav-1P) on a-SMA expression in ECs from Cav1 KO mice.
Pulmonary ECs from two Cav1 KO mice were treated with TGF-b1
with or without 5 mmol/L cav-1P or 5 mmol/L control peptide
(ConP) for 72 hours. A: Cell lysates were probed with a-SMA. GAPDH
was used as loading control. The bars show quantitative densitom-
etry of a-SMA analyzed using ImageJ software. The experiment was
performed in triplicate. The values shown are the mean  SE of the
triplicates. B and C: Expression levels of Acta2 (B) and Col1a1 (C)
in WT and Cav1 KO mice as determined by semiquantitative RT-PCR.
Values represent the mean  SD expression levels of three replicates
of two separate experiments with ECs isolated from three WT and
three Cav1 KO mice. CT values were normalized with Gapdh. The
saline control levels were arbitrarily set at 100% expression. Values
for other samples are expressed relative to the saline control.
Signiﬁcance was determined by the two-tailed t-test. *P < 0.1,
**P < 0.01.
Li et alculture dishes with control or cav-1p peptide for 24 hours,
followed by 72 hours with or without TGF-b1 (10 ng/mL),
andwere harvested using a cell lifter, washed in cold PBS, and
processed for RNA extraction (RNeasy kit; Qiagen Inc.,
Valencia, CA), including a genomic DNA digestion step.
Total RNA (1 mg) was reverse transcribed using SuperScript
II Reverse Transcriptase (Invitrogen) to generate ﬁrst-strand
cDNA. The primers were designed using Vector NTI soft-
ware version 5 (Invitrogen) andwere validated for speciﬁcity.
The following primers were used for standard RT-PCR:
Snai1: forward, 50-ACCTTCCAGCAGCCCTACGA-30; re-
verse, 50-AGCGTGTGGCTTCGGATGTG-30, and Gapdh:
forward, 50-TGTGGATGGCCCCTCTGGAA-30; reverse,
50-CGGCATCGAAGGTGGAAGAG-30. Standard RT-PCR
was performed following a standard ampliﬁcation protocol.
The reaction cycles were an initial denaturation at 95C for
3 minutes and replicate for 35 cycles at 95C for 30 seconds,
61C (for Snai1) or 59C (for Gapdh) for 45 seconds, and
72C for 45 seconds, and followed by 72C for 7minutes. The
products were electrophoresed on 1% agarose gels stained
with ethidium bromide. The reaction productswere visualized
using a FluorImager system (Molecular Dynamics, Sunny-
vale, CA). Imageswere quantitated by using ImageJ software,
and the signals were normalized to those of Gapdh.
For quantitative RT-PCR, EC transcript levels were
quantiﬁed using SYBR Green real-time PCR, as previously
described.30 Primers were designed using Primer Express
software version 3.0 (Applied Biosystems, Foster City, CA)
and were validated for speciﬁcity. The following primers
were used: Gapdh: forward, 50-CATGGCCTTCCGTGTT-
CCTA-30; reverse, 50-CCTGCTTCACCACCTTCTTGA T-30,
Col1a1: forward, 50-GCATGGCCAAGAAGACATCG-30;







GCT-30. The differences in the number of mRNA copies
in each PCR were corrected for Gapdh endogenous
control transcript levels; levels in control experiments
were set at 100%, and all other values are expressed as
multiples of control values.
Statistical Analysis
Values reﬂect the mean  SD of separate experiments, each
performed in triplicate. The statistical signiﬁcance of all the
data was assessed by the two-tailed t-test. A P < 0.05 was
considered statistically signiﬁcant.
Results
Herein, we describe studies examining the participation of
CAV1 in the EndoMT process using pulmonary ECs from328 ajp.amjpathol.org - The American Journal of Pathology
Figure 3 Increased Snai1 expression and protein levels in Cav1/
pulmonary ECs. Pulmonary ECs isolated from two WT and two Cav1 KO
mice were treated with TGF-b1 for 72 hours. A: RNA was puriﬁed,
reverse transcribed, and assessed by PCR for Snai1, Snai2, and Gapdh
expression. The ﬁgure shows representative results from three separate
experiments. B: Cell lysates from one of the experiments underwent
Western blot analysis for SNAIL1 levels. The bars show quantitative
densitometry using ImageJ software. The values are the mean  SE of
two different experiments. C and D: Expression levels of Snai1 (C) and
Snai2 (D) in WT and Cav1 KO mice as determined by semiquantitative
RT-PCR. Values represent the mean  SD expression levels of three
replicates of two separate experiments with ECs isolated from three WT
and three Cav1 KO mice. CT values were normalized with Gapdh. The
saline control levels were arbitrarily set at 100% expression. Values for
other samples are expressed relative to the saline control. Signiﬁcance
was determined by the two-tailed t-test. *P < 0.1, **P < 0.01, and
***P < 0.001.
Caveolin-1 Deﬁciency Induces EndoMTWT and Cav1 KO mice. Isolation of pulmonary ECs used
a sequential immunomagnetic puriﬁcation of enzymatically
dissociated lung cells with anti-CD31 followed by anti-C102
antibodies as described previously.22 This procedure yields
an essentially pure (95% to 98%) EC population as identiﬁed
by their cellular morphology and their uptake of DiI-labeled
acetylated low-density lipoprotein, as described in Materials
and Methods. The results with pulmonary ECs derived from
two Cav1 KO mice showed high and spontaneous constitu-
tive expression of a-SMA by immunoﬂuorescence staining.
Furthermore, CAV1 deﬁciency increased a-SMA expression
induced by treatment with TGF-b1 (Figure 1A). These results
were conﬁrmed by Western blot assays that showed very
high spontaneous expression of a-SMA in Cav1 KO cells
and a further increase in these levels after TGF-b treatment
(Figure 1B). Western blot analysis of culture media for type I
collagen, a characteristic mesenchymal cell product, showed
high levels in the culture media of untreated Cav1 KO cells,
with a further increase after exposure to TGF-b (Figure 1C).
A cell-permeable CAV1 scaffolding domain peptide previ-
ously shown to cause selective restoration of functional
CAV1 domains20,29 caused a potent reduction in sponta-
neous and TGF-bestimulated a-SMA protein expression,
whereas a control peptide lacking the CAV1 sequence had no
such effects (Figure 2A). These effects on Acta2 expression
were conﬁrmed by quantitative RT-PCR on total EC RNA
isolated from an additional three WT and three Cav1 KO
mice (Figure 2B). Expression of the Col1a1 gene was also
induced in these cells by TGF-b, and this increased expres-
sion was reversed by preincubation with the CAV1 scaf-
folding domain peptide (Figure 2C).
The molecular mechanisms involved in EndoMT have
not been completely elucidated, although current evidence
indicates that the transcriptional repressor SNAIL1 is
involved.22e25SNAIL1 is a zincﬁnger transcription factor that
regulates transcription of the E-cadherin gene in cultured
cells24 and plays a crucial role in the process of epithelial-to-
mesenchymal transition.24,25 SNAIL2 has also been impli-
cated in epithelial-to-mesenchymal transition.31 Herein, we
observed remarkable spontaneous increased expression of
Snai1 and Snai2 in pulmonary ECs by standard RT-PCR from
Cav1 KOmice that was further increased after treatment with
TGF-b1 (Figure 3A). A similar pattern of changes in SNAIL1
protein levels was observed in cell lysates by Western blot
analysis (Figure 3B).Analysis of cells from an additional three
WT and threeCav1KOmice by quantitative RT-PCR showed
similarly striking TGF-bedependent up-regulation of Snai1
(Figure 3C) and Snai2 (Figure 3D) expression and that pre-
incubation with the cav-1P peptide completely abrogated the
increased expression levels of both genes (Figure 3, C and D).
Discussion
EndoMT is a process whereby ECs transdifferentiate into
mesenchymal cells, losing their EC-speciﬁc functions andThe American Journal of Pathology - ajp.amjpathol.org 329
Li et alinitiating the expression of a-SMA, E-cadherin, and inter-
stitial collagens, such as type I collagen.9,10 EndoMT has
recently been reported in experimentally induced cardiac,
pulmonary, and renal ﬁbrosis (reviewed by Piera-Velazquez
et al11,12).
CAV1 is the main protein component of 50- to 100-nm
ﬂask-shaped invaginations found on the plasma membrane
known as caveolae (reviewed in other studies13,14). CAV1
plays an important role in the internalization, trafﬁcking, and
degradation of TGF-b receptors15; therefore, it plays a crucial
role in the regulation of TGF-b signaling and TGF-be
mediated ﬁbrotic responses.16 CAV1 has been shown to be
down-regulated in affected tissues from patients with SSc and
idiopathic pulmonary ﬁbrosis,17,18 and restoration of CAV-1
functional domains or adenoviral-mediated expression of
CAV1 abrogated bleomycin-induced pulmonary ﬁbrosis in
mice.19 Previous studies of Cav1 KO mice are in support of
this notion.17,27 Although the earlier description of these
mice27 was not focused on the development of tissue ﬁbrosis,
the presence of markedly abnormal alveolar spaces that
appeared constricted by thickened alveolar septa and hyper-
cellularity, and thickening of the alveolar basement
membrane including accumulation and disorganization of
reticulin ﬁbers were noted. The subsequent study17 was
focused on the ﬁbrotic and connective tissue abnormalities in
Cav1 KO mice. The results showed a marked increase in
interstitial collagen evidenced by trichrome staining and
a >2.5-fold increase in lung hydroxyproline content, a direct
and quantitative reﬂection of the extent of tissue ﬁbrosis.
The results described herein demonstrate the spontaneous
occurrence of EndoMT in Cav1/ pulmonary ECs as
evidenced by the high constitutive expression of a-SMA,
the high levels of the mesenchymal cell product type I
collagen, and the high expression of the transcriptional
repressors Snai1 and Snai2, molecules previously shown to
be up-regulated in TGF-b1einduced EndoMT in normal
murine pulmonary ECs. These observations support the
concept that EndoMT may occur spontaneously in Cav1-
deﬁcient mice in vivo and may play a crucial role in the
ﬁbrotic process previously described in these mice.17,26
The results described herein suggest that caveolin
deﬁciencyemediated EndoMT may participate in the
development of proliferative vasculopathy in diseases
such as SSc and idiopathic pulmonary ﬁbrosis.Acknowledgment
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